116 related articles for article (PubMed ID: 36470150)
1. Taurine induces upregulation of p53 and Beclin1 and has antitumor effect in human nasopharyngeal carcinoma cells in vitro and in vivo.
Okano M; He F; Ma N; Kobayashi H; Oikawa S; Nishimura K; Tawara I; Murata M
Acta Histochem; 2023 Jan; 125(1):151978. PubMed ID: 36470150
[TBL] [Abstract][Full Text] [Related]
2. Anti-Cancer Mechanisms of Taurine in Human Nasopharyngeal Carcinoma Cells.
He F; Ma N; Midorikawa K; Hiraku Y; Oikawa S; Mo Y; Zhang Z; Takeuchi K; Murata M
Adv Exp Med Biol; 2019; 1155():533-541. PubMed ID: 31468429
[TBL] [Abstract][Full Text] [Related]
3. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
[TBL] [Abstract][Full Text] [Related]
4. Taurine exhibits an apoptosis-inducing effect on human nasopharyngeal carcinoma cells through PTEN/Akt pathways in vitro.
He F; Ma N; Midorikawa K; Hiraku Y; Oikawa S; Zhang Z; Huang G; Takeuchi K; Murata M
Amino Acids; 2018 Dec; 50(12):1749-1758. PubMed ID: 30225664
[TBL] [Abstract][Full Text] [Related]
5. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY
J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682
[TBL] [Abstract][Full Text] [Related]
6. Anticancer targets and mechanisms of calycosin to treat nasopharyngeal carcinoma.
Liu F; Pan Q; Wang L; Yi S; Liu P; Huang W
Biofactors; 2020 Jul; 46(4):675-684. PubMed ID: 32449282
[TBL] [Abstract][Full Text] [Related]
7. Pentagalloylglucose suppresses the growth and migration of human nasopharyngeal cancer cells via the GSK3β/β-catenin pathway in vitro and in vivo.
Fan CW; Tang J; Jiang JC; Zhou MM; Li MS; Wang HS
Phytomedicine; 2022 Jul; 102():154192. PubMed ID: 35636179
[TBL] [Abstract][Full Text] [Related]
8. Autophagy related 4B, upregulated by HIF-1α, attenuates the sensitivity to cisplatin in nasopharyngeal carcinoma cells.
Huang J; Li HB; Yu S; Yuan F; Lou ZP
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4793-4802. PubMed ID: 32432742
[TBL] [Abstract][Full Text] [Related]
9. MDM2 inhibitor RG7388 potently inhibits tumors by activating p53 pathway in nasopharyngeal carcinoma.
Fan X; Wang Y; Song J; Wu H; Yang M; Lu L; Weng X; Liu L; Nie G
Cancer Biol Ther; 2019; 20(10):1328-1336. PubMed ID: 31311404
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway.
Guo S; Zhang J; Wei C; Lu Z; Cai R; Pan D; Zhang H; Liang B; Zhang Z
Cancer Chemother Pharmacol; 2020 Jun; 85(6):1097-1108. PubMed ID: 32449143
[TBL] [Abstract][Full Text] [Related]
11.
Zhu Q; Zhang Q; Gu M; Zhang K; Xia T; Zhang S; Chen W; Yin H; Yao H; Fan Y; Pan S; Xie H; Liu H; Cheng T; Zhang P; Zhang T; You B; You Y
Autophagy; 2021 Jul; 17(7):1667-1683. PubMed ID: 32627648
[TBL] [Abstract][Full Text] [Related]
12. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
[TBL] [Abstract][Full Text] [Related]
13. Preclinical efficacy and involvement of mTOR signaling in the mechanism of Orf virus against nasopharyngeal carcinoma cells.
Huang Y; Gong K; Chen J; Deng H; Weng K; Wu H; Li K; Xiao B; Luo S; Hao W
Life Sci; 2022 Feb; 291():120297. PubMed ID: 35007565
[TBL] [Abstract][Full Text] [Related]
14. BIX-01294-enhanced chemosensitivity in nasopharyngeal carcinoma depends on autophagy-induced pyroptosis.
Li Q; Wang M; Zhang Y; Wang L; Yu W; Bao X; Zhang B; Xiang Y; Deng A
Acta Biochim Biophys Sin (Shanghai); 2020 Oct; 52(10):1131-1139. PubMed ID: 33085742
[TBL] [Abstract][Full Text] [Related]
15. LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2.
Gong Z; Zhang S; Zeng Z; Wu H; Yang Q; Xiong F; Shi L; Yang J; Zhang W; Zhou Y; Zeng Y; Li X; Xiang B; Peng S; Zhou M; Li X; Tan M; Li Y; Xiong W; Li G
PLoS One; 2014; 9(11):e110674. PubMed ID: 25422887
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of autophagy by chloroquine makes chemotherapy in nasopharyngeal carcinoma more efficient.
Aga T; Endo K; Tsuji A; Aga M; Moriyama-Kita M; Ueno T; Nakanishi Y; Hatano M; Kondo S; Sugimoto H; Wakisaka N; Yoshizaki T
Auris Nasus Larynx; 2019 Jun; 46(3):443-450. PubMed ID: 30514592
[TBL] [Abstract][Full Text] [Related]
17. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W
Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitization of Clioquinol Combined with Zinc in the Nasopharyngeal Cancer Stem-like Cells by Inhibiting Autophagy in Vitro and in
Ke Y; Wu C; Zeng Y; Chen M; Li Y; Xie C; Zhou Y; Zhong Y; Yu H
Int J Biol Sci; 2020; 16(5):777-789. PubMed ID: 32071548
[TBL] [Abstract][Full Text] [Related]
19. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X
J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354
[TBL] [Abstract][Full Text] [Related]
20. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
